人福医药：招商生物拟增持0.5%-1%公司股份

Core Viewpoint - The announcement indicates that招商生物 plans to increase its stake in人福医药 within six months, reflecting confidence in the company's future development and long-term investment value [1] Group 1: Shareholding Plan - 招商生物 intends to acquire between 0.5% and 1% of人福医药's total issued share capital through various trading methods [1] - The maximum purchase price is set at 25.53 yuan per share [1] Group 2: Current Shareholding Status - 招商生物 currently holds no shares in人福医药 but controls 23.70% of the voting rights through the restructuring plan of当代科技 [1] Group 3: Purpose of the Increase - The increase in shareholding is based on招商生物's confidence in人福医药's future and recognition of its long-term investment value [1]